Levels vs Mars Petcare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Levels pioneered metabolic health tracking using continuous glucose monitors (CGMs) paired with an AI-powered app; raised $38M Series A from a16z; expanding into clinician-ready Levels Pro platform in 2026.
About
Levels is a metabolic health company that pairs continuous glucose monitors (CGMs) with a mobile app and AI-driven insights to help users understand how food, exercise, stress, and sleep affect their blood sugar and overall metabolic health. Founded in 2019 and headquartered in the US, Levels was one of the first companies to bring CGM-based metabolic monitoring to non-diabetic consumers, pioneering a category that has since attracted major competitors and FDA-cleared OTC devices.
World's largest pet company with $22B+ revenue across Pedigree, Whiskas, Royal Canin, Banfield Pet Hospitals, and VCA; Mars family-owned competing with Nestlé Purina across nutrition and veterinary care.
About
Mars Petcare is the world's largest pet nutrition and veterinary healthcare company — a division of Mars, Incorporated (the private family-owned global confectionery and food conglomerate) producing market-leading pet food brands including Pedigree (dog food), Whiskas (cat food), Royal Canin (premium veterinary prescription nutrition), Iams, Sheba, Cesar, and Temptations, while also operating the Banfield Pet Hospital chain (1,000+ locations), VCA Animal Hospitals (1,000+ locations), BluePearl Veterinary Partners (specialty and emergency hospitals), and Antech Diagnostics (veterinary laboratory services). Mars Petcare generates estimated revenues of $22+ billion annually.
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.